Crosscheck

Your medical. Crosschecked.

Allergy and cold

Steroid nasal sprays

Nasal corticosteroid spray
Other names: Flonase, Veramyst, Xhance, Nasonex, Nasacort, Rhinocort

FAA guidance

Acceptable with conditions.

Wait

no wait after the first dose or after later doses (the FAA's MedGuide)

Two FAA documents give different waits. Both are below.

Examiner

The examiner can issue when the document's criteria are met

FAA label

ACCEPTABLE

Source: FAA, Allergy – Antihistamines & Immunotherapy Medication. FAA date 30 September 2026. Checked by Crosscheck 14 October 2026

The FAA's two documents on steroid nasal sprays give different waits.

Track your medications
Compare FAA documents: Steroid nasal spraysWhat each of the three FAA documents says, in plain wordsOpen

The FAA's documents differ. The FAA's allergy sheet requires a 48-hour ground trial after the first use of any new medication; the FAA's MedGuide, newer and written medicine by medicine, gives these no wait after the first dose. Both are current FAA documents and both name the medicine, so neither is set aside.

Wait

  • 48-hour ground trial after first use of any new medication (the FAA's allergy sheet)

The FAA's MedGuide names beclomethasone (Beconase AQ, Qnasl), budesonide (Rhinocort), ciclesonide (Omnaris, Zetonna), flunisolide (Nasalide), fluticasone (Flonase, Veramyst, Xhance), mometasone furoate (Nasonex) and triamcinolone (Nasacort) nasal sprays as allowed, for allergic rhinitis (fluticasone also for nasal polyps), with no wait after the first dose, after later doses or after the final dose.

The FAA's allergy sheet lists corticosteroid nasal sprays as acceptable allergy medication, which may be used as a single agent or in any combination product, if other certification criteria are met. Under new medications, the allergy sheet says symptoms must be controlled without adverse side effects and a mandatory 48-hour ground trial is required after initial use; for acceptable medications, it says the initial observation time is not required (see chart below); and its footnote prohibits flight/safety-related duties after initial use of a new medication until after a 48-hour ground trial and no side effects are noted. The allergy sheet also says airmen who are exhibiting symptoms, regardless of the treatment used, must not fly.

The FAA's general over-the-counter guide lists fluticasone (Flonase), mometasone (Nasonex) and triamcinolone (Nasacort) among its nasal steroid allergy products in its "Generally Safe to Fly" column. The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.

Show the FAA's words: Steroid nasal spraysThe official FAA wording: four passages, each with its document and dateOpen
FAA, Allergy – Antihistamines & Immunotherapy Medication · FAA date 30 September 2026
New medications:
Symptoms must be controlled without adverse side effects.
Initial observation time: Mandatory 48-hour ground trial required after initial use.
Acceptable medications:
Initial observation time: Not required for acceptable medications (see chart below).
ACCEPTABLE* (Non-Sedating) Antihistamine and Allergy Medications
May be used as a single agent or in any combination product, if other certification criteria are met.
Nasal spray: Corticosteroid
* Airmen are prohibited from flight/safety-related duties after initial use of a new medication until after a 48-hour ground trial and no side effects are noted.
Generic: beclomethasone (nasal)
Brand Name: Beconase AQ; Qnasl
Drug Class: Corticosteroid, nasal
Underlying Condition: Allergic rhinitis
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: budesonide (nasal)
Brand Name: Rhinocort
Drug Class: Corticosteroid, nasal
Underlying Condition: Allergic rhinitis
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
Generic: ciclesonide (nasal)
Brand Name: Omnaris; Zetonna
Drug Class: Corticosteroid, nasal
Underlying Condition: Allergic rhinitis
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: flunisolide (nasal)
Brand Name: Nasalide [INTL]
Drug Class: Corticosteroid, nasal
Underlying Condition: Allergic rhinitis
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: fluticasone (nasal)
Brand Name: Flonase; Veramyst; Xhance
Drug Class: Corticosteroid, nasal
Underlying Condition: Allergic rhinitis; Nasal polyps
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
Generic: mometasone furoate (nasal)
Brand Name: Nasonex
Drug Class: Corticosteroid, nasal
Underlying Condition: Allergic rhinitis
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
Generic: triamcinolone (nasal)
Brand Name: Nasacort
Drug Class: Corticosteroid, nasal
Underlying Condition: Allergic rhinitis
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
FAA, Allergy – Antihistamines & Immunotherapy Medication · FAA date 30 September 2026
Airmen who are exhibiting symptoms, regardless of the treatment used, must not fly.
FAA, What Over-the-Counter (OTC) Medications Can I Take and Still Be Safe to Fly? · FAA date 28 August 2024
GENERALLY SAFE TO FLY
GO
Nasal steroid Allergy products azelastine (Astepro) fluticasone (Flonase) mometasone (Nasonex) triamcinolone (Nasacort)
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Sources and dates: Steroid nasal spraysThree FAA documents, with the FAA's date and when Crosscheck checked themOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.